Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0032273 (
pneumoconiosis
)
1,578
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate the occurrence of Branhamella catarrhalis respiratory tract infections in 109 outpatients with
pneumoconiosis
, clinical and bacteriological studies were performed during a 4-year period from April 1984 to March 1988. B. catarrhalis was isolated in 26 patients; only three of these received continuous corticosteroid treatment. The incidence of B. catarrhalis respiratory tract infections increased gradually during the years 1984-1986, but decreased for the first time in 1987 compared with the previous year. There was a seasonal variation in isolations with a peak incidence during the winter, a pattern in contrast to Haemophilus influenzae. Almost all isolates produced
beta-lactamase
. B. catarrhalis found in mixed culture was usually in association with H. influenzae or Streptococcus pneumoniae. The isolation rates for B. catarrhalis in sputum of patients with
pneumoconiosis
followed those of H. influenzae and S. pneumoniae, and almost all strains were positive for
beta-lactamase
, so B. catarrhalis should be admitted that it is a primary pathogen.
...
PMID:[Respiratory tract infections caused by Branhamella catarrhalis in outpatients with pneumoconiosis]. 250 94
The clinical significance of Branhamella catarrhalis in respiratory infections is evaluated. 175 strains were isolated, mainly from the sputum, in 71 patients with respiratory infections. B. catarrhalis was most frequently isolated in mixed infections with Haemophilus influenzae (38.3%), H. influenzae plus Streptococcus pneumoniae (10.3%) or S. pneumoniae (9.7%). The rate of isolation of B. catarrhalis alone was as low as 5.1% and from mixed infections with Pseudomonas aeruginosa, Escherichia coli, and Enterobacter and/or Klebsiella species it was 36.6%. More than 10(7) cfu/ml of B. catarrhalis were isolated from 71.4% of cases. In 29 cases the organism was determined to be causative according to our criteria, most often in secondary infections in patients with complicated
pneumoconiosis
, chronic bronchitis and bronchiectasis. 29 of 47 strains (61.7%) produced
beta-lactamase
of the
penicillinase
type. Against these strains, penicillin antibiotics and first and second generation cephalosporin antibiotics (except cefroxadine) showed weak activity compared with their activity against non-
beta-lactamase
-producing strains. The third generation cephalosporins showed a uniform spectrum of activity against both groups of organisms.
...
PMID:Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections. 348 1